Can an MRI Be Wrong? A Look at Accuracy & Limitations

Discover what influences MRI accuracy. Learn about factors affecting image quality, interpretation, and the inherent limitations of scans.

MRI scans can absolutely be wrong, and the ways they go wrong are more varied than most people realize. An MRI might miss a real problem, flag something harmless as alarming, or produce images so degraded by movement or metal that a radiologist draws the wrong conclusion. A systematic review and meta-analysis found that when MRI interpretations are sent for a second opinion, roughly 31% of readings show some discrepancy with the original report. That does not mean nearly a third of MRIs are useless, but it does mean the technology has real limits worth understanding.

How Often Two Radiologists Disagree

One of the most striking findings in radiology research is how frequently two qualified readers looking at the same MRI arrive at meaningfully different conclusions. A meta-analysis across imaging types found that the overall discrepancy rate for MRI second-opinion readings was about 31%, with rates varying by specialty: roughly 34% for musculoskeletal imaging, about 24% for neuroradiology, and nearly 33% for oncologic imaging. These are not trivial differences in phrasing. A study of musculoskeletal MRI second opinions found that about a quarter of cases had clinically important discrepancies, and in oncologic cases the figure was over a third. When pathology later confirmed which reading was correct, the subspecialist second opinion turned out to be right roughly 82% of the time.

In rectal cancer staging, the picture is even starker. A study comparing initial MRI reports with subspecialist second reads found discordance in over half of cases, and more than half of those discordant readings were classified as major disagreements that could change treatment decisions. The takeaway is not that MRI is unreliable. It is that reading an MRI is a skilled act of interpretation, and the reader’s subspecialty experience matters as much as the scanner itself.

When MRI Misses a Real Problem

False negatives are among the most dangerous MRI failures, and they happen more often in some clinical scenarios than others. Stroke is the classic example. Diffusion-weighted imaging is the go-to MRI technique for spotting acute strokes, but it does not catch every one, especially when the scan is done very early or the stroke is in certain parts of the brain.

A study of patients who arrived with sudden neurological deficits found that about 6% had a negative initial diffusion-weighted scan but turned out to have a confirmed stroke on follow-up imaging. The miss rate shot up for strokes in the back of the brain: roughly 19% of strokes in the vertebrobasilar territory were missed on the first scan, compared with just 2% of those in the front-of-brain circulation. Among patients scanned within 24 hours of symptom onset, nearly a third of posterior-circulation strokes were missed. Timing matters enormously here. Research on transient ischemic attacks showed that the probability of a false-negative diffusion-weighted scan dropped from 25% at one hour after symptoms to 7% at three hours, and no false negatives were seen in patients imaged beyond three hours.

Clinicians who suspect stroke despite a clean MRI increasingly rely on additional imaging sequences like perfusion mapping or repeat scanning. A case report of a 75-year-old woman who woke with left-sided weakness illustrated this well: her initial diffusion-weighted MRI was completely normal, but perfusion imaging revealed reduced blood flow in the right hemisphere, and angiography found a blocked internal carotid artery. Follow-up scans confirmed a large infarct. The lesson is that a clean MRI early after symptom onset does not rule out stroke, and doctors know to keep looking.

When MRI Finds Something That Does Not Matter

The opposite problem is just as common and arguably more disruptive to patients: MRI picks up something that looks abnormal but is either harmless or completely unrelated to the patient’s symptoms. A large systematic review and meta-analysis of brain and body MRI scans in apparently healthy adults found that about 4% of scans turned up “potentially serious” incidental findings. When the definition was expanded to include findings of uncertain seriousness, the figure rose to nearly 13%. About half of those seemingly serious findings were suspected malignancies. Yet when researchers followed up on what actually happened, only about one in five of the “potentially serious” findings turned out to have a genuinely serious final diagnosis.

Brain MRI in the general population is a particularly rich source of incidental findings. A large population-based study found asymptomatic brain infarcts in about 7% of participants, cerebral aneurysms in roughly 2%, and benign primary tumors (mostly meningiomas) in about 1.6%. Many of these findings never cause symptoms. But once a patient knows about them, a cascade of anxiety, further testing, and sometimes unnecessary procedures can follow.

The Spine Findings Almost Everyone Has

Nowhere is the incidental-finding problem more consequential than in spinal imaging. If you scan the lower backs of people with zero pain, you will find abnormalities in the majority of them. A landmark study in the New England Journal of Medicine scanned 98 people who had no back pain and found that 52% had a disc bulge at one or more levels, 27% had a disc protrusion, and 38% had abnormalities at more than one disc.

A more recent systematic review found that these findings become almost universal with age. Among people in their twenties with no symptoms, about 37% already showed disc degeneration. By age 80, it was 96%. Disc bulges increased from 30% in 20-year-olds to 84% in 80-year-olds. These numbers mean that when a patient with back pain gets an MRI and the report mentions disc bulges or degeneration, there is a real chance those findings would be present whether they had pain or not. The MRI is not “wrong” in the technical sense; it accurately captures what the spine looks like. But interpreting those findings as the cause of pain is a separate clinical judgment, and that judgment is frequently wrong.

This is why orthopedic and spine specialists emphasize that MRI results should never be read in isolation. As one widely cited clinical commentary put it: if the MRI shows something unexpected, the doctor should go back to the patient’s history and physical examination to check whether the complaint can actually be attributed to those imaging findings. If it cannot, the findings should not drive treatment.

False Alarms and Missed Cancers

Cancer detection is where false positives and false negatives carry the heaviest emotional and medical weight. Prostate MRI using the standardized PI-RADS scoring system has improved cancer detection compared with blind biopsy, but the error rates are still substantial. A diagnostic meta-analysis across multiple studies found pooled sensitivity of about 78% and specificity of about 79% for prostate cancer detection. In practical terms, that means roughly one in five clinically significant cancers is missed, and about one in five flagged areas turns out to be benign.

The real-world numbers can be even more lopsided. One study of over 2,500 patients found that 52% of MRI-positive cases were false positives on subsequent biopsy, while about 16% of patients with negative MRI results actually did have cancer. Another study found false-positive rates exceeding 50%, with the highest rates occurring in the intermediate-suspicion scoring category. These false positives lead to biopsies that come back negative, creating stress and procedural risk for patients.

Breast MRI faces a related challenge. It is probably the most sensitive method available for detecting breast lesions, catching tumors that mammography misses. But that sensitivity comes at a cost: breast MRI is relatively non-specific, meaning it has difficulty distinguishing benign from malignant lesions. The result is increased biopsy rates driven by false-positive findings, and most of those biopsies reveal benign tissue. This is a fundamental tradeoff in cancer imaging: higher sensitivity means catching more real cancers, but also flagging more things that are not cancer.

When Treatment Looks Like Disease Coming Back

After treatment for brain tumors, MRI faces a particularly tricky problem called pseudoprogression. On a standard post-treatment scan, an area of new or enlarging contrast enhancement can appear, looking for all the world like the tumor is growing back. But in many cases, the changes are caused by treatment effects like inflammation or disruption of the blood-brain barrier, and they will subside on their own without any change in therapy. Standard structural MRI sequences cannot reliably tell the difference between pseudoprogression and real recurrence. Distinguishing the two requires advanced imaging techniques such as perfusion MRI, and getting it right matters enormously: misidentifying pseudoprogression as recurrence could lead a patient to start an aggressive new treatment they do not need.

Evaluating treatment response for brain metastases from other cancers poses similar challenges. A systematic review found that conventional anatomical MRI had a pooled sensitivity of about 79% and specificity of 76% for distinguishing treatment response from progression. Combining multiple MRI techniques pushed those numbers up to roughly 84% sensitivity and 88% specificity, but still left meaningful room for error.

Technical Factors That Degrade the Image

An MRI is only as good as the images it produces, and several technical factors can degrade quality enough to cause errors.

Patient movement during the scan is one of the most common culprits. Even small movements can cause ghosting, blurring, or signal changes that confuse interpretation, particularly in sequences with low signal-to-noise ratios or when looking for small lesions. A study of stroke MRI found that motion artifacts appeared in about 7% of scans and significantly reduced the accuracy of detecting hemorrhage, with accuracy dropping from 100% to 93% for human readers and from 88% to 67% for an AI tool. Older patients and those with limb weakness were more likely to produce motion artifacts, which is unfortunate since those are precisely the people most likely to be scanned for stroke.

Metallic implants are another major source of image degradation. Joint replacements, spinal hardware, dental implants, and other metal in the body create magnetic field distortions that can cause signal loss, geometric warping, and bright pile-up artifacts on the images. These artifacts can obscure the very tissues the scan was ordered to evaluate, compromising diagnostic accuracy around the implant. Specialized metal-artifact-reduction sequences exist and are improving, but many facilities still use standard protocols that leave significant blind spots around hardware.

Body size also affects image quality. When standard body coils are used for larger patients, the signal-to-noise ratio drops, and the resulting images can be noticeably lower in contrast. One study found signal and contrast reductions of up to roughly 35% in obese patients scanned with body coils compared with normal-weight patients using optimized surface coils. Open-bore and wide-bore MRI scanners accommodate larger patients more comfortably, but they sometimes sacrifice field strength or coil proximity, creating their own tradeoffs.

Does a Bigger Magnet Mean a Better Scan?

Many patients assume that a 3-Tesla MRI is automatically better than a 1.5-Tesla machine. The physics are straightforward: a stronger magnet produces a higher signal-to-noise ratio, which means sharper images. A knee-imaging study confirmed that 3T provided roughly twice the signal of 1.5T and modestly improved sensitivity for cartilage abnormalities. But sharper images do not always translate into better diagnoses.

A systematic review of 150 studies comparing 1.5T and 3T brain MRI found that while 3T images were often described as “crisper,” there was little evidence of improved diagnostic accuracy in most clinical scenarios. The advantages were largely limited to research applications like functional MRI and spectroscopy. Breast MRI told a similar story: a prospective comparison found that sensitivity, specificity, and overall accuracy were statistically indistinguishable between 1.5T and 3T scanners. If you are being offered a choice between scanners, the radiologist reading the images and the protocol being used matter more than the number on the magnet.

Protocol Choices and Where MRI Falls Short

Even with perfect hardware, the wrong imaging protocol can cause errors. MRI relies on different pulse sequences to highlight different tissue properties, and choosing the wrong sequence for the clinical question can cause lesions to be missed or mischaracterized. This is well documented in liver imaging, where the selection of pulse sequences and imaging parameters directly affects whether a lesion is detected and correctly identified. A scan ordered with a generic “abdomen” protocol when a specific liver-lesion protocol was needed can produce perfectly fine-looking images that simply do not contain the diagnostic information the clinician requires.

There are also anatomical areas where MRI is fundamentally less capable than other imaging modalities. The lungs are the classic example. Because lung tissue is mostly air, MRI generates very little signal from it. CT remains superior for detecting small lung nodules under 6 millimeters. A patient who has a chest MRI for a different reason should not assume their lungs have been adequately screened; that is a job for CT.

Why “Low-Value” MRIs Keep Getting Ordered

Understanding why MRIs go wrong also means understanding why so many scans are ordered in situations where they are unlikely to help. Patient pressure, defensive medical practice, risk aversion, and gaps in clinician education all drive the ordering of MRIs that are not clinically indicated. A scan ordered for vague back pain in a young person without red-flag symptoms will almost certainly find disc bulges or other degenerative changes, because those are present in a large fraction of healthy people. The scan is not wrong. It is being asked a question it cannot usefully answer.

This is not a harmless problem. Every incidental finding can trigger a cascade of follow-up tests, specialist referrals, and patient anxiety that would never have occurred if the scan had not been done. The MRI becomes the first domino in a chain of events that creates cost and risk without improving the patient’s outcome.

How AI Is Changing the Picture

Artificial intelligence is being developed as a second set of eyes rather than a replacement for the radiologist. In breast MRI, one study found that when radiologists used an AI decision-support system, their average diagnostic accuracy improved modestly but meaningfully, with sensitivity rising from about 90% to 94% when using a standard reporting threshold.

For spine imaging, a deep-learning system embedded directly into the MRI scanner was tested in over 1,500 patients and showed high performance across multiple spinal conditions, with area-under-the-curve values exceeding 0.95 for the AI-assisted approach compared with over 0.90 for fully manual reading. The system also improved positioning accuracy during the scan itself and reduced variability between different readers. These tools are promising, but the motion-artifact study mentioned earlier provides a cautionary note: the same AI that improved baseline accuracy took a bigger accuracy hit from motion artifacts than human readers did. AI systems trained on clean images may struggle with the messy reality of clinical scans from patients who cannot hold still.

What You Can Actually Do About It

If you are wondering whether your own MRI result might be wrong, a few practical things are worth knowing. Staying as still as possible during the scan is the single easiest thing you can do to improve image quality. If you have metal implants, make sure the ordering physician and the MRI technologist both know, so they can choose artifact-reduction sequences. If your scan was done at a general imaging center for a complex problem like a suspected tumor or an unusual joint injury, asking whether a subspecialist radiologist has reviewed the images is reasonable. The evidence consistently shows that subspecialty second reads change the interpretation in a meaningful fraction of cases.

If MRI findings do not match your symptoms, that disconnect is itself useful clinical information. A disc bulge on MRI in someone whose pain pattern and physical exam point to a completely different cause should not drive surgical decision-making. The scan is a tool, not a verdict, and the doctors who use it best are the ones who treat it that way.